Skip to content

FDM PHARMA

Active Private limited companyfounded 2014active for 12 yearsRue Wattelar Maximilien 68, 6040 CharleroiKBO/BCE: BE 0546.573.521

Lifetime

12 annual accounts with figures on one time axis
peak of €1.0m in 2025
€1.0m▲ 16.1%
peak of €357,146 in 2025
€357,146▲ 15.7%
peak of €1.8m in 2025
€1.8m▲ 23.9%
€990,519▼ 44.2%
peak of 3 FTE in 2025
3 FTE▲ 66.7%
Board1 name since 2014
1 director
Documentsfilings and deeds
31-07-2026on the last day
2025abbreviated format
Gross margin from €899,567 to €1.0mStaff from 1.8 FTE to 3 FTEEquity from €1.5m to €1.8mDebts from €1.8m to €990,519Cash from €1.2m to €537,485

Key points

from the 2025 annual accounts

Equity

€1.8m ▲ 23.9%

FDM PHARMA has made a profit in every financial year since 2014.

Investments

€2,390 0.0 times depreciation
20212022202320242025

Green is investment, beige is depreciation.

Staff

4 employees on 31-12-2025
312021312022102023012024312025

In 2025, 3 employees joined and 1 left.

Liquidity

5.03 was 1.86 in 2024

Short-term debts fell from €936,873 to €322,116.

Filings

12 annual accounts since 2014
AprilJune31 JulyOctober201520202025

Six of the last ten came late. The 2021 accounts came in latest, 31 days after the end of the period.

Position in the sector

€357,146

Higher net result than 93% of companies in retail trade. The sector median is €38,025, over 13,284 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,726 companies had the same profile as FDM PHARMA has now. Each dot stands for 87 companies, two years later.

95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,726 companies, not a prediction for FDM PHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 21-01-2021
  • deed of 09-02-2021

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0546573521
Merger: takes over Dissolution of the company · Company renamed to FDM PHARMA · Dissolved without liquidation · General meeting of 21-01-2021 · Gazette deed
Merger: FDM PHARMA takes over FDM PHARMA Gazette deed
Demerger proposal: FDM Pharma splits off to The company holds all the shares of FDM Pharma · Gazette deed
All 27 events

Comparable companies

same main activity, similar in size and age
Company
FDM PHARMA Charleroi €2.8m €1.0m 65.1% 3
Pharmacie GLORIEUX Farciennes €2.9m €0.9m 68.1% 4.6
Apomertens Hulshout €3.0m €0.7m 41.8% 4
EDIS INVEST Molenbeek-Saint-Jean €2.3m €0.6m 8.5% 2.8
JECO FARMA Brakel €3.4m €0.9m 66.9% 3.9
PHARMA POSITIVE Woluwe-Saint-Lambert €2.1m €0.9m 27.6% 4.4
Pharmacie de Gistoux Chaumont-Gistoux €2.6m €0.9m 41.5% 4.8

These companies have the same main activity as FDM PHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €2.1m and €3.4m, founded between 2007 and 2014.

Official details

Source: KBO
Status
Active since 14-02-2014Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 1 other
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.226.974.2036040 Charleroi, registered on 25-02-2014
Financial year end
31 December
Peppol
Reachable since 31-10-2024
Company details

Annual accounts 2025

≈ €2.8mestimated
€2.8m▼ 13.1%
Employeeson 31-12-2025
4▲ 100%
Filing
Filed on 31-07-2026, on the last day of the filing period
Financials

Insights on FDM PHARMA

FDM PHARMA files the abbreviated format. That format states no turnover. The gross margin rose from €32,918 in 2014 to €1.0m in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about FDM PHARMA

What is the company number of FDM PHARMA?
The company number of FDM PHARMA is 0546.573.521. The VAT number is the same number with BE in front: BE 0546.573.521.
Where is FDM PHARMA based?
The registered office is at Rue Wattelar Maximilien 68, 6040 Charleroi.Company details
What does FDM PHARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of FDM PHARMA?
FDM PHARMA is a private limited company (BV).
When was FDM PHARMA founded?
FDM PHARMA was founded on 14-02-2014.
Is FDM PHARMA still active?
Yes, FDM PHARMA is an active enterprise in the KBO register.
How many employees does FDM PHARMA have?
FDM PHARMA had an average of 3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does FDM PHARMA fall under?
In its 2025 annual accounts, FDM PHARMA states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of FDM PHARMA?
The turnover in financial year 2025 is about €2.8m. This figure is estimated from the gross margin of €1.0m and 31 comparable companies (NACE 477). It probably lies between €2.1m and €3.9m.
Is FDM PHARMA profitable?
In financial year 2025, FDM PHARMA made a profit of €357,146.
Where can I find the annual accounts of FDM PHARMA?
FDM PHARMA filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of FDM PHARMA due?
FDM PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.